Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026)

Zymeworks' (ZYME) quarterly Other Non-Current Liabilities came in at $278000.0 in Q1 2026, down 67.52% year-on-year from $856000.0 in Q1 2025, and little changed quarter-over-quarter from $278000.0 in Q4 2025.

Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $278000.0 for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $278000.0, down 67.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $278000.0 (down 67.52% YoY), and the FY2025 annual result was $278000.0, down 69.88% from the prior year.
  • Other Non-Current Liabilities came in at $278000.0 for Q1 2026 at Zymeworks, roughly flat from $278000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.9 million in Q3 2022 to a low of $278000.0 in Q3 2025.
  • The 5-year median for Other Non-Current Liabilities is $929000.0 (2024), against an average of $1.1 million.
  • Across the five-year window, Other Non-Current Liabilities sank 90.01% in 2023 and surged 217.06% in 2024, its largest moves.
  • Zymeworks' Other Non-Current Liabilities stood at $1.6 million in 2022, then grew by 3.59% to $1.7 million in 2023, then plunged by 45.74% to $923000.0 in 2024, then sank by 69.88% to $278000.0 in 2025, then changed by 0.0% to $278000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $278000.0 (Q1 2026), $278000.0 (Q4 2025), and $278000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Zymeworks 1.73 Bn 1.36 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 278,000.00
Dec 31, 2025 278,000.00
Sep 30, 2025 278,000.00
Jun 30, 2025 828,000.00
Mar 31, 2025 856,000.00
Dec 31, 2024 923,000.00
Sep 30, 2024 929,000.00
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 293,000.00
Jun 30, 2023 1.06 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 2.93 Mn
Dec 31, 2021 2.75 Mn